RENE — ReNeuron Share News
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- £1.93m
- -£2.80m
- £0.53m
REG - ReNeuron Group plc - Product Development Update
AnnouncementREG - ReNeuron Group plc - Block Listing Review and TVR <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Block Listing Application <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Positive pre-clinical data in nerve injury <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementRCS - ReNeuron Group plc - Phase II stroke data presented at AHA conference <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Approval of Share Capital Reorganisation <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Further re Share Capital Reorganisation <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Proposed Share Capital Reorganisation <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Interim results <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Stroke clinical trial regulatory approval in US <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - ReNeuron opens US office <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Notification of Interim Results <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Retinal disease clinical trial moves into Phase II <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Positive stroke clinical data & regulatory update <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Wins further UK grant <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - PDMR Interest in Shares and Share Options <Origin Href="QuoteRef">RQE.L</Origin> - Part 1
AnnouncementREG - ReNeuron Group plc - PDMR Interest in Shares and Share Options <Origin Href="QuoteRef">RQE.L</Origin> - Part 2
AnnouncementREG - ReNeuron Group plc - Presentation of positive pre-clinical data <Origin Href="QuoteRef">RQE.L</Origin>
AnnouncementREG - ReNeuron Group plc - Directors' Interest in Shares and Share Options <Origin Href="QuoteRef">RQE.L</Origin>
Announcement